©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 112981
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112981
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112981
Figure 2 The construction of the nomogram.
A: The nomogram for predicting the 3-month and 6-month progression-free survival; B: The nomogram for predicting the 12-month, 15-month, and 18-month overall survival. PD-L1: Programmed cell death ligand 1; MMR: Mismatch repair; dMMR: Deficient mismatch repair; pMMR: Proficient mismatch repair; NLR: Neutrophil-to-lymphocyte ratio; CALLY: C-reactive protein-albumin-lymphocyte; PFS: Progression-free survival; OS: Overall survival.
- Citation: Yao ZY, Bao G, Li GC, Hao QL, Ma LJ, Rao YX, Xu K, Ma X, Han ZX. Survival prognosis in advanced HER-2 negative gastric cancer treated with immunochemotherapy: A novel model. World J Gastrointest Oncol 2025; 17(11): 112981
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/112981.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.112981